Z-2184-2018 Class II Ongoing
FDA device recall Z-2184-2018 was initiated by Cellavision AB on Dec 4, 2017 and is designated Class II. Reason for recall: A software malfunction was found where WBC, RBC and PLT comments added after a slide is signed, are not sent to the LIS. This can only occur where customers process multiple slides per blood sample. The recall status is ongoing. Affected quantity: Instruments: 224 Software: 99 (US).
Recall details
- Product Type
- Devices
- Report Date
- Jun 20, 2018
- Initiation Date
- Dec 4, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- Instruments: 224 Software: 99 (US)
Product description
Reason for recall
Distribution pattern
US Nationwide in the states of FL, IL, NY, and NC
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2184-2018
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Cellavision AB? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.